Signet matched its rival’s mixed performance in the last decade, gaining ground through most of the Dot.com bear market and then stalling out in the upper-30s in 2002. It rallied above that level in 2004 and dropped into a holding pattern until a 2006 breakout added just six points into the 2007 May top at $49.00. The subsequent decline did extensive technical...
Champions Oncology Inc. (CSBR) develops novel technologies for oncology diagnosis and treatment. It topped out at $23.88 in 2013 and entered a decline that posted an all-time low at $1.11 in August 2016. A basing pattern into November got bought, lifting the stock into a recovery wave that broke out above the 200-day EMA in January 2017. It topped out and rolled...
Cogentix Medical Inc. (CGNT) topped out in the mid-20s in 2005 and tested that resistance level in 2008. It then entered a severe downtrend that continued into the May 2016 all-time low at 71-cents. Price action since that time has carved a multi-leg recovery, with the stock recently bouncing off new support at the 200-day EMA under $2.00. Pullbacks to the blue...
EyeGate Pharmaceuticals Inc. (EYEG) had the misfortune of entering into a worldwide licensing agreement with Valeant Pharmaceuticals International Inc. (VRX) in July 2015, just before scandal rocked the blue chip drug manufacturer. It hit an all-time high at $35 after the news and then plummeted, dropping back into single digits in August. The stock posted lower...
Antares Pharma Inc. (ATRS) develops and markets injector solutions for a variety of self-administered therapies. It rallied sharply off the December 2008 bear market low at 29-cents, reaching an all-time high at $5.58 in July 2012. The subsequent downtrend finally ended at 67-cents in March 2016, giving way to a channeled uptick that remains in force more than...
Retailer Naked Brand Group Inc. (NAKD) entered into a January 2017 merger agreement with New Zealand intimate apparel manufacturer Bendon that will require new stock issuance after shareholder approval. The news ignited a vertical buying spike to $3.68, followed by a steep decline to $1.14 at the start of February. Dip buyers emerged at that level, triggering a...
Western Copper & Gold Corp. (WRN) topped out with world commodity markets in 2011, posting an all-time high at $4.49, ahead of a brutal downtrend that hit an all-time low at 20-cents in January 2016. The subsequent recovery wave stalled just above a buck in July, giving way to a narrow consolidation that yielded a December breakout up to $1.80. It’s been grinding...
Pulmatrix Inc. (PULM) develops therapies for the treatment of pulmonary diseases. It came public above $20 in March 2014 and entered a severe downtrend that continued into the start of 2017, dropping to an all-time low at 50-cents. The stock went vertical in early February, after meeting Nasdaq exchange compliance issues, and stalled following a 950K secondary...
Zosano Pharma Corp. (ZSAN) came public near $11 in January 2015 and entered a stairstep decline that initially found support near $2.00 at the start of 2016. That level broke mid-year, dumping to an all-time low at 45-cents in November, ahead of a bounce into 2017. The stock charged higher in February, breaking out above the 200-day EMA, after a migraine relief...
MobileIron Inc. (MOBL) peaked at $12.96 in August 2014 and dropped a trading range that broke to the downside in April 2015. Bears kept control into the September 2015 low at $2.81, ahead of a bounce that stalled at the 200-day EMA in April 2016. It broke 2015 support in September and turned sharply higher in October, returning to range resistance one month later....